Global Anti–vascular Endothelial Growth Factor Therapy Market Growth (Status and Outlook) 2022-2028
- LP 4857781
- 61 Pages
- February 2022
- Pharmaceuticals
The United States Anti–vascular Endothelial Growth Factor Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anti–vascular Endothelial Growth Factor Therapy market, reaching US$ million by the year 2028. As for the Europe Anti–vascular Endothelial Growth Factor Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Anti–vascular Endothelial Growth Factor Therapy players cover Regeneron Pharmaceuticals (Eylea), Genentech, Kanghong Pharmaceutical, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti–vascular Endothelial Growth Factor Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Extraction Injection
Precharge Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Macular Degeneration
Nacular Edema
Uveitis
Retinal Vein Occlusion
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Regeneron Pharmaceuticals (Eylea)
Genentech
Kanghong Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Size 2017-2028
2.1.2 Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Anti–vascular Endothelial Growth Factor Therapy Segment by Type
2.2.1 Extraction Injection
2.2.2 Precharge Injection
2.3 Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
2.3.1 Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2017-2022)
2.4 Anti–vascular Endothelial Growth Factor Therapy Segment by Application
2.4.1 Macular Degeneration
2.4.2 Nacular Edema
2.4.3 Uveitis
2.4.4 Retinal Vein Occlusion
2.5 Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
2.5.1 Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2017-2022)
3 Anti–vascular Endothelial Growth Factor Therapy Market Size by Player
3.1 Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Players
3.1.1 Global Anti–vascular Endothelial Growth Factor Therapy Revenue by Players (2020-2022)
3.1.2 Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Players (2020-2022)
3.2 Global Anti–vascular Endothelial Growth Factor Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anti–vascular Endothelial Growth Factor Therapy by Regions
4.1 Anti–vascular Endothelial Growth Factor Therapy Market Size by Regions (2017-2022)
4.2 Americas Anti–vascular Endothelial Growth Factor Therapy Market Size Growth (2017-2022)
4.3 APAC Anti–vascular Endothelial Growth Factor Therapy Market Size Growth (2017-2022)
4.4 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Growth (2017-2022)
5 Americas
5.1 Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2017-2022)
5.2 Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2017-2022)
5.3 Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2017-2022)
6.2 APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2017-2022)
6.3 APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Anti–vascular Endothelial Growth Factor Therapy by Country (2017-2022)
7.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2017-2022)
7.3 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy by Region (2017-2022)
8.2 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.1 Global Anti–vascular Endothelial Growth Factor Therapy Forecast by Regions (2023-2028)
10.1.1 Global Anti–vascular Endothelial Growth Factor Therapy Forecast by Regions (2023-2028)
10.1.2 Americas Anti–vascular Endothelial Growth Factor Therapy Forecast
10.1.3 APAC Anti–vascular Endothelial Growth Factor Therapy Forecast
10.1.4 Europe Anti–vascular Endothelial Growth Factor Therapy Forecast
10.1.5 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Forecast
10.2 Americas Anti–vascular Endothelial Growth Factor Therapy Forecast by Country (2023-2028)
10.2.1 United States Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.2.2 Canada Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.2.3 Mexico Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.2.4 Brazil Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.3 APAC Anti–vascular Endothelial Growth Factor Therapy Forecast by Region (2023-2028)
10.3.1 China Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.3.2 Japan Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.3.3 Korea Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.3.4 Southeast Asia Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.3.5 India Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.3.6 Australia Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.4 Europe Anti–vascular Endothelial Growth Factor Therapy Forecast by Country (2023-2028)
10.4.1 Germany Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.4.2 France Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.4.3 UK Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.4.4 Italy Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.4.5 Russia Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.5 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Forecast by Region (2023-2028)
10.5.1 Egypt Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.5.2 South Africa Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.5.3 Israel Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.5.4 Turkey Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.5.5 GCC Countries Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.6 Global Anti–vascular Endothelial Growth Factor Therapy Forecast by Type (2023-2028)
10.7 Global Anti–vascular Endothelial Growth Factor Therapy Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Regeneron Pharmaceuticals (Eylea)
11.1.1 Regeneron Pharmaceuticals (Eylea) Company Information
11.1.2 Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Product Offered
11.1.3 Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Regeneron Pharmaceuticals (Eylea) Main Business Overview
11.1.5 Regeneron Pharmaceuticals (Eylea) Latest Developments
11.2 Genentech
11.2.1 Genentech Company Information
11.2.2 Genentech Anti–vascular Endothelial Growth Factor Therapy Product Offered
11.2.3 Genentech Anti–vascular Endothelial Growth Factor Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Genentech Main Business Overview
11.2.5 Genentech Latest Developments
11.3 Kanghong Pharmaceutical
11.3.1 Kanghong Pharmaceutical Company Information
11.3.2 Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Product Offered
11.3.3 Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Kanghong Pharmaceutical Main Business Overview
11.3.5 Kanghong Pharmaceutical Latest Developments
12 Research Findings and Conclusion
Table 1. Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Extraction Injection
Table 3. Major Players of Precharge Injection
Table 4. Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2017-2022)
Table 7. Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2017-2022)
Table 10. Global Anti–vascular Endothelial Growth Factor Therapy Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Player (2020-2022)
Table 12. Anti–vascular Endothelial Growth Factor Therapy Key Players Head office and Products Offered
Table 13. Anti–vascular Endothelial Growth Factor Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Regions (2017-2022)
Table 18. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Country (2017-2022)
Table 20. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2017-2022)
Table 22. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2017-2022)
Table 24. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Region (2017-2022)
Table 26. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2017-2022)
Table 28. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2017-2022)
Table 30. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Country (2017-2022)
Table 32. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2017-2022)
Table 34. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Anti–vascular Endothelial Growth Factor Therapy
Table 43. Key Market Challenges & Risks of Anti–vascular Endothelial Growth Factor Therapy
Table 44. Key Industry Trends of Anti–vascular Endothelial Growth Factor Therapy
Table 45. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share Forecast by Application (2023-2028)
Table 51. Regeneron Pharmaceuticals (Eylea) Details, Company Type, Anti–vascular Endothelial Growth Factor Therapy Area Served and Its Competitors
Table 52. Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Product Offered
Table 53. Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Regeneron Pharmaceuticals (Eylea) Main Business
Table 55. Regeneron Pharmaceuticals (Eylea) Latest Developments
Table 56. Genentech Details, Company Type, Anti–vascular Endothelial Growth Factor Therapy Area Served and Its Competitors
Table 57. Genentech Anti–vascular Endothelial Growth Factor Therapy Product Offered
Table 58. Genentech Main Business
Table 59. Genentech Anti–vascular Endothelial Growth Factor Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Genentech Latest Developments
Table 61. Kanghong Pharmaceutical Details, Company Type, Anti–vascular Endothelial Growth Factor Therapy Area Served and Its Competitors
Table 62. Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Product Offered
Table 63. Kanghong Pharmaceutical Main Business
Table 64. Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Kanghong Pharmaceutical Latest Developments
List of Figures
Figure 1. Anti–vascular Endothelial Growth Factor Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type in 2021
Figure 7. Anti–vascular Endothelial Growth Factor Therapy in Macular Degeneration
Figure 8. Global Anti–vascular Endothelial Growth Factor Therapy Market: Macular Degeneration (2017-2022) & ($ Millions)
Figure 9. Anti–vascular Endothelial Growth Factor Therapy in Nacular Edema
Figure 10. Global Anti–vascular Endothelial Growth Factor Therapy Market: Nacular Edema (2017-2022) & ($ Millions)
Figure 11. Anti–vascular Endothelial Growth Factor Therapy in Uveitis
Figure 12. Global Anti–vascular Endothelial Growth Factor Therapy Market: Uveitis (2017-2022) & ($ Millions)
Figure 13. Anti–vascular Endothelial Growth Factor Therapy in Retinal Vein Occlusion
Figure 14. Global Anti–vascular Endothelial Growth Factor Therapy Market: Retinal Vein Occlusion (2017-2022) & ($ Millions)
Figure 15. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application in 2021
Figure 16. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Player in 2021
Figure 17. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size 2017-2022 ($ Millions)
Figure 19. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size 2017-2022 ($ Millions)
Figure 20. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size 2017-2022 ($ Millions)
Figure 22. Americas Anti–vascular Endothelial Growth Factor Therapy Value Market Share by Country in 2021
Figure 23. Americas Anti–vascular Endothelial Growth Factor Therapy Consumption Market Share by Type in 2021
Figure 24. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application in 2021
Figure 25. United States Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Region in 2021
Figure 30. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application in 2021
Figure 31. China Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Country in 2021
Figure 38. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type in 2021
Figure 39. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application in 2021
Figure 40. Germany Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application in 2021
Figure 48. Egypt Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 54. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 55. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 57. United States Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 58. Canada Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 61. China Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 62. Japan Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 63. Korea Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 65. India Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 66. Australia Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 67. Germany Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 68. France Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 69. UK Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 70. Italy Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 71. Russia Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 72. Spain Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 75. Israel Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Anti–vascular Endothelial Growth Factor Therapy Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
